Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperpigmentation | 1 | 2024 | 117 | 0.850 |
Why?
|
Administration, Cutaneous | 1 | 2024 | 711 | 0.810 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2020 | 22 | 0.690 |
Why?
|
Injections, Intralesional | 1 | 2020 | 277 | 0.660 |
Why?
|
Acne Vulgaris | 1 | 2024 | 355 | 0.650 |
Why?
|
Mycosis Fungoides | 1 | 2020 | 167 | 0.620 |
Why?
|
Antioxidants | 1 | 2024 | 1668 | 0.540 |
Why?
|
Cyclin-Dependent Kinase 6 | 3 | 2024 | 346 | 0.490 |
Why?
|
Skin Neoplasms | 2 | 2021 | 5796 | 0.370 |
Why?
|
Nanoparticles | 1 | 2021 | 1935 | 0.330 |
Why?
|
Laser Therapy | 2 | 2024 | 1093 | 0.280 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2021 | 4025 | 0.250 |
Why?
|
Salicylic Acid | 1 | 2024 | 64 | 0.240 |
Why?
|
Glass | 1 | 2024 | 115 | 0.220 |
Why?
|
Erythema | 1 | 2024 | 262 | 0.210 |
Why?
|
Eyelashes | 1 | 2022 | 19 | 0.210 |
Why?
|
Eyebrows | 1 | 2022 | 35 | 0.210 |
Why?
|
Skin Aging | 1 | 2024 | 141 | 0.200 |
Why?
|
Skin Pigmentation | 1 | 2024 | 277 | 0.200 |
Why?
|
Lipogenesis | 1 | 2024 | 209 | 0.200 |
Why?
|
Lasers, Solid-State | 1 | 2024 | 175 | 0.190 |
Why?
|
Ascorbic Acid | 1 | 2024 | 655 | 0.190 |
Why?
|
Hidradenitis Suppurativa | 1 | 2024 | 173 | 0.180 |
Why?
|
Adhesives | 1 | 2021 | 64 | 0.180 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 381 | 0.170 |
Why?
|
Glycerol | 1 | 2021 | 278 | 0.170 |
Why?
|
Adipose Tissue, White | 2 | 2024 | 365 | 0.170 |
Why?
|
Polyesters | 1 | 2021 | 371 | 0.160 |
Why?
|
Camptothecin | 1 | 2021 | 588 | 0.140 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2021 | 625 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2020 | 601 | 0.130 |
Why?
|
Immunomodulation | 1 | 2020 | 547 | 0.130 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2018 | 352 | 0.130 |
Why?
|
Choroid Plexus | 1 | 2016 | 237 | 0.110 |
Why?
|
Polymers | 1 | 2021 | 1618 | 0.110 |
Why?
|
HIV Infections | 1 | 2020 | 17128 | 0.110 |
Why?
|
Combined Modality Therapy | 1 | 2024 | 8549 | 0.100 |
Why?
|
Adipose Tissue, Brown | 1 | 2018 | 755 | 0.100 |
Why?
|
Ribonucleases | 1 | 2012 | 275 | 0.100 |
Why?
|
Hydrocephalus | 1 | 2016 | 763 | 0.090 |
Why?
|
Oncogene Protein v-akt | 1 | 2009 | 129 | 0.080 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2009 | 81 | 0.080 |
Why?
|
Ribonuclease, Pancreatic | 1 | 2009 | 149 | 0.080 |
Why?
|
RNA, Ribosomal | 1 | 2009 | 226 | 0.080 |
Why?
|
Biopsy | 1 | 2020 | 6772 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10827 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 64879 | 0.070 |
Why?
|
Neurogenesis | 1 | 2012 | 854 | 0.070 |
Why?
|
Neovascularization, Physiologic | 1 | 2012 | 1336 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 21981 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2020 | 11123 | 0.060 |
Why?
|
Erbium | 1 | 2024 | 13 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2020 | 12964 | 0.060 |
Why?
|
Cell Line, Tumor | 1 | 2021 | 16871 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10734 | 0.060 |
Why?
|
Fluorides | 1 | 2024 | 134 | 0.050 |
Why?
|
Mice | 5 | 2024 | 81138 | 0.050 |
Why?
|
Humans | 10 | 2024 | 759255 | 0.050 |
Why?
|
Gene Expression Regulation | 1 | 2018 | 11908 | 0.040 |
Why?
|
Animals | 6 | 2024 | 167838 | 0.040 |
Why?
|
Hair | 1 | 2022 | 491 | 0.040 |
Why?
|
Alopecia | 1 | 2022 | 414 | 0.040 |
Why?
|
Male | 5 | 2024 | 358719 | 0.040 |
Why?
|
Young Adult | 1 | 2024 | 58483 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13621 | 0.040 |
Why?
|
Crosses, Genetic | 1 | 2018 | 752 | 0.030 |
Why?
|
Drug Resistance, Bacterial | 1 | 2024 | 1053 | 0.030 |
Why?
|
Female | 4 | 2024 | 390240 | 0.030 |
Why?
|
Adolescent | 1 | 2024 | 87560 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2018 | 1174 | 0.030 |
Why?
|
Cerebral Ventricles | 1 | 2016 | 543 | 0.030 |
Why?
|
Adult | 2 | 2024 | 219390 | 0.030 |
Why?
|
Inpatients | 1 | 2024 | 2580 | 0.030 |
Why?
|
Oxygen Consumption | 1 | 2018 | 1840 | 0.020 |
Why?
|
Child | 1 | 2020 | 79623 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2018 | 686 | 0.020 |
Why?
|
Adipocytes | 1 | 2018 | 1179 | 0.020 |
Why?
|
Middle Aged | 2 | 2024 | 219653 | 0.020 |
Why?
|
Neomycin | 1 | 2009 | 93 | 0.020 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2009 | 189 | 0.020 |
Why?
|
Dactinomycin | 1 | 2009 | 303 | 0.020 |
Why?
|
Pain | 1 | 2024 | 5058 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2012 | 1900 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2414 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2817 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7514 | 0.020 |
Why?
|
Aged | 1 | 2020 | 168617 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10181 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 11324 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2024 | 7380 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2009 | 674 | 0.020 |
Why?
|
Transcription Factors | 1 | 2024 | 12106 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6070 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 25860 | 0.010 |
Why?
|
Transcriptional Activation | 1 | 2009 | 1756 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14381 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2012 | 4286 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9374 | 0.010 |
Why?
|
Base Sequence | 1 | 2012 | 12450 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2018 | 11476 | 0.010 |
Why?
|
Phenotype | 1 | 2018 | 16532 | 0.010 |
Why?
|
Up-Regulation | 1 | 2009 | 4132 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2009 | 3443 | 0.010 |
Why?
|
Cell Line | 1 | 2012 | 15636 | 0.010 |
Why?
|
Obesity | 1 | 2018 | 12896 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2009 | 7595 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2009 | 10440 | 0.010 |
Why?
|
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_